Using Mendelian randomization to evaluate the effects of alcohol consumption on the risk of coronary heart disease
PURPOSE: This paper aims to evaluate the use of Mendelian randomization (MR) analyses for judging the effects of alcohol consumption on the risk of coronary heart disease (CHD).
DESIGN/METHODOLOGY/APPROACH/ This paper presents a review of methodology for MR and describes its early application to judging health effects of alcohol, current uses and a recommended approach of combining MR results with those from observational and experimental studies.
FINDINGS: Early applications of MR to health effects of alcohol consumption were inadequate for providing unbiased results, but newer attempts using polygenic scores show promise. It is important to combine data from MR analyses with those from observational and experimental studies to obtain an unbiased and scientifically sound estimate of alcohol’s effects on health.
PRACTICAL IMPLICATIONS: Giving advice to the public regarding alcohol consumption must be based on accurate, unbiased scientific data; this paper describes attempts to use MR for achieving this goal.
SOCIAL IMPLICATIONS: Given that light-to-moderate alcohol intake is associated with a lower risk of CHD, type II diabetes mellitus and total mortality, it is important to be able to evaluate both the benefits and harms from alcohol before giving advice regarding drinking.
ORIGINALITY/VALUE: This is part of a group of three papers dealing with the potential health benefits and harms associated with alcohol consumption.
Additional Info
-
Authors
Grø nbæ Ellison R. Curtis; k Morten; Skovenborg Erik -
Issue
Drugs and Alcohol Today, Vol. 21 No. 1, pp. 84-95. https://doi.org/10.1108/DAT-09-2020-0061 -
Published Date
15 january 2021
Related items
- Mediterranean diet: definitions, health effects and metabolic pathways – evidence and future directions
- Interpreting the Evidence on Wine Consumption and Health: A Narrative Review of the J-Shaped Association and Contemporary Alcohol Guidelines
- Attitudes Toward Cancer and Heart Disease Warning Labels on Alcoholic Beverages in the United States
- Age at first drink below 19 years and all-cause mortality in Chinese older adults: a 10-year prospective cohort study
- Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial